Latest News

  • AI Sepsis Diagnosis, PathAI, Google Cloud Team Up, More

    Diagnostics World | Roche will distribute Prenosis’s Sepsis ImmunoScore, an artificial intelligence/machine learning software as a medical device to guide rapid diagnosis of sepsis and prediction of adverse outcomes; PathAI announced a strategic partnership with Google Cloud at Bio-IT World Conference & Expo to help biopharma companies and anatomic pathology labs accelerate the adoption of AI and digital pathology; more.

    Apr 25, 2024
  • Follow the Money: Novel T Cell Program, Respiratory Diagnostics, Generative AI For Small Molecule Therapies

    Diagnostics World | Asher Therapeutics will advance the clinical development of its lead program, AB248, a novel CD8+ T cell selective IL-2, generated by fusing a reduced potency IL-2 mutein to an anti-CD8β antibody; Kryptos Biotechnologies will further develop Kryptos’s flagship point-of-care molecular diagnostics system Kuick and advance the clinical study of the respiratory combo tests; DeepCure plans to advance its generative AI and physics-based engine to innovate the discovery of small molecule therapies for challenging targets; more.

    Apr 24, 2024
  • Novel Diagnostic System Finds Role of Immune System in Alzheimer’s Disease

    Diagnostics World | Researchers in Denmark have devised a blood-based diagnostic technique that can detect even trace amounts of an aggregated protein indicative of Alzheimer’s disease before any disease-related changes show up on a PET scan, one of the traditional testing methods. The same technology can be used for developing new therapies by revealing what part of the innate immune system is engaged in the fight.

    Apr 18, 2024
  • MRD Futures for Pharma

    Diagnostics World | Minimal residual disease testing (MRD) has been gaining ground in diagnostics, and a panel took on the topic at the Precision Medicine TriCon late last month.

    Apr 17, 2024
  • Age of Opportunity: Artificial Intelligence and the Precision Medicine Future

    Diagnostics World | At the Precision Med TriConference 2024, Illumina Ventures partner Mara Aspinall sat with Eric Topol, endowed chair and executive VP and professor at Scripps Translational Science Institute, in a fireside chat to discuss precision medicine and artificial intelligence (AI). With three published books and more than 1,200 peer reviewed publications, Topol is one of the industry’s leading minds on digital medicine, and from his perspective, AI needs to be adapted sooner.

    Apr 16, 2024